1. The use of enzalutamide (Xtandi) and abiraterone (Zytiga) in metastatic castration-sensitive prostate cancer (mCSPC) was associated with similar overall survival (OS). 2. The use of enzalutamide was associated with...
1. Among women with prediabetes following prior gestational diabetes mellitus (GDM), intermittent metformin (Glucophage) in combination with lifestyle modifications was non-inferior to continuous metformin in combination with lifestyle modifications. Evidence...
1. ARPA-H selected innovation teams in June 2026 for the ADVOCATE program, a three-year federally funded effort to build the first FDA-authorized autonomous AI agent capable of providing around-the-clock specialty...
1. In this single-group, open-label trial, olorofim was associated with a complete or partial clinical response in over 75% of patients with disseminated coccidioidomycosis (DCM) and limited or no treatment...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
1. The EAST-AFNET 4 trial (East AF) demonstrated that early rhythm control therapy—including antiarrhythmic drugs or catheter ablation—was associated...
1. In this systematic review and meta-analysis, catheter ablation was found to reduce overall risk of ischemic stroke, hospitalization...
1. In this retrospective cohort study, breast cancer survivors had a lower risk of Alzheimer’s dementia compared with cancer-free...
1. For patients with facet-mediated spine pain that achieve ≥80% pain relief after a medial branch block, a second...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.